| Gene symbol | STEAP2 | Synonyms | IPCA1, PCANAP1, PUMPCn, STAMP1, STMP | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7q21.13 | dbXrefs | |
| Description | STEAP2 metalloreductase | ||||
| GTO ID | GTC3761 |
| Trial ID | NCT06267729 |
| Disease | Prostate Cancer |
| Altered gene | STEAP2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | AZD0754 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Phase I/II Open Label Study to Evaluate the Safety, Cellular Kinetics, and Efficacy of AZD0754, a Chimeric Antigen Receptor (CAR) T-cell Therapy Directed Against STEAP2, in Adult Participants With Metastatic Prostate Cancer: APOLLO |
| Year | 2024 |
| Country | Australia|United States |
| Company sponsor | AstraZeneca |
| Other ID(s) | D9660C00001 |
| Cohort 1 | |||||||||
|
|||||||||